6 Dimensions Capital
6 Dimensions Capital is a healthcare focused investment firm.
Business Model:
Revenue: $31.4M
Employees: 201-500
Rankings
Industries / Tags:
Detailed 6 Dimensions Capital Information
Geographic Data
Address: 33, Zhanghe Road,
City: Shanghai
State: shanghai municipality
Zip: 201203
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
6 Dimensions Capital was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The two prominent and experienced teams formed a healthcare focused investment firm with an in-depth focus and extensive coverage both in China and global market.
Contact Phone:
+18620287698
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2018 | Gracell Biotechnologies | Series A | - |
| 5/2021 | Engine Biosciences | Series A | 0 |
| 12/2020 | Exo Therapeutics | Series A | 25M |
| 8/2018 | WiseTek | Seed Round | 437.7k |
| 10/2017 | Helian Health | Series A | 9M |
| 2/2019 | NeuSpera Medical | Series B | 12M |
| 7/2018 | Lyvgen | Series B | 30M |
| 1/2018 | Engine Biosciences | Seed Round | 10M |
| 12/2020 | MitrAssist | Venture Round | 0 |
| 11/2020 | Kira Pharmaceuticals | Venture Round | - |
| 5/2020 | Haoxinqing | Series A | 0 |
| 2/2018 | Viela Bio | Series A | 0 |
| 11/2017 | AnchorDx | Series B | 28M |
| 3/2018 | IDEAYA Biosciences | Series B | 0 |
| 7/2018 | Curon Biopharma | Series A | 150M |
| 1/2020 | TScan Therapeutics | Series B | 35M |
| 6/2019 | Ultivue | Series C | 22M |
| 11/2017 | Semma Therapeutics | Series B | 0 |
| 8/2018 | GloriousMed Technology | Series A | 11M |
| 3/2018 | Forerunner Medical | Venture Round | - |
| 1/2021 | FogPharma | Series C | 107M |
| 3/2018 | Biokangtai | Post-IPO Equity | - |
| 3/2018 | UNITY Biotechnology | Series C | 55M |
| 1/2018 | Ultivue | Series B | 20M |
| 2/2019 | Halda Therapeutics | Series A | 0 |
| 11/2018 | Kymera Therapeutics | Series B | 65M |
| 1/2019 | Dewpoint Therapeutics | Series A | 60M |
| 4/2020 | ITeos Therapeutics | Series B | 0 |
| 4/2018 | Yiyao | Series E | 50M |
| 1/2018 | NeuSpera Medical | Series B | 26M |
| 9/2018 | Fulcrum Therapeutics | Series B | 80M |
| 11/2013 | Jiecheng Medical | Series A | 1.6M |
| 11/2021 | Ignis Therapeutics | Series A | 0 |
| 1/2021 | TScan Therapeutics | Series C | 100M |
| 5/2018 | Brii Biosciences | Venture Round | 260M |
| 5/2018 | CStone Pharmaceuticals | Series B | 260M |
| 2/2019 | HiberCell | Series A | 60.8M |
| 5/2018 | Grail | Series C | 0 |
| 9/2019 | GKHT Medical Technology | Series C | 154.5M |
| 3/2018 | TCR2 | Series B | 0 |
| 6/2018 | ITeos Therapeutics | Series B | 0 |
| 11/2017 | Medeor Therapeutics | Series B | 0 |
| 3/2020 | Kymera Therapeutics | Series C | 102M |
| 3/2018 | Hua Medicine | Series D | 0 |
| 5/2018 | FogPharma | Series B | 66M |
| 10/2021 | Exo Therapeutics | Series B | 0 |
| 11/2021 | Ignis Therapeutics | Series A | 0 |
| 10/2021 | Exo Therapeutics | Series B | 0 |
| 5/2021 | Engine Biosciences | Series A | 0 |
| 1/2021 | TScan Therapeutics | Series C | 0 |
| 1/2021 | FogPharma | Series C | 0 |
| 12/2020 | Exo Therapeutics | Series A | 0 |
| 12/2020 | MitrAssist | Venture Round | 0 |
| 11/2020 | Kira Pharmaceuticals | Venture Round | - |
| 5/2020 | Haoxinqing | Series A | 0 |
| 4/2020 | ITeos Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
